Delivery Order SPE2DB25D3504-SPE2DB26FVTFW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,063.60 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) 40 mg/0.4 mL prefilled pens. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of August 5, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded a $13,075.97 delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) prefilled pens, 40 mg/0.4 mL dosage. This contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a $6,405.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 ml dosage. This is a non-set-aside, competitively awarded contract with a completion date of September 29, 2025, and performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, due for completion by June 2, 2025. The award was issued on May 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) prefilled pens, 40 mg/0.4 mL formulation, valued at $6,797.70 with a firm fixed price structure. Awarded on September 15, 2025, this non-set-aside delivery order is scheduled for completion by September 16, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,957.76 to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of HUMIRA (Adalimumab) prefilled pens at 40 mg/0.4 mL. This firm fixed-price delivery order represents a non-set-aside competitive award with an ultimate completion date of September 22, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as...
- The Defense Logistics Agency awarded a delivery order valued at $1,352.00 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL, with an ultimate completion date of August 7, 2025. This non-competitive delivery order represents a firm fixed-price transaction issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,915.60 to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) Pen 40 mg/0.4 mL on August 19, 2025, with completion scheduled for August 20, 2025. This delivery order represents a firm fixed-price procurement with no set-aside designation, competitively awarded through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $9,739.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of HUMIRA (adalimumab) Pen 40 mg/0.4 mL units. This non-competitive delivery order is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB26FVTFWDelivery Order
The Defense Logistics Agency awarded a $8,891.14 delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) 40 mg/0.4 mL pre-filled pens on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-competitive delivery order was issued under firm fixed price terms and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs across military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply brand-name and generic medications, vaccines, specialty pharmaceuticals, and related medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to competitively meet the Defense Logistics Agency's pharmaceutical procurement requirements and serve the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 10/20/25 |